Effects of MK-3475 (Pembrolizumab) on the Breast Tumor Microenvironment in Triple Negative Breast Cancer
Clinical trial NCT02977468 · UNKNOWN
Trial details
- NCT number
- NCT02977468
- Sponsor
- Eileen Connolly
- Status
- UNKNOWN
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-10-25
- Primary completion
- 2024-12-31
- Enrollment
- 15
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.